US STOCKS S&P 500 struggles for direction as new COVID worries outweigh stimulus-passage boost


NEW YORK, Dec 22 (Reuters) - The S&P 500 was essentially unchanged on Tuesday as worries over a new variant of COVID-19 and downbeat economic data dampened enthusiasm over the passage of a long-awaited pandemic relief bill in Washington.

The Dow was lower, while Apple Inc (AAPL.O) helped fuel the tech-heavy Nasdaq's advance.

"The market trades in anticipation of an event," said Robert Pavlik, senior portfolio manager at Dakota Wealth in Fairfield, Connecticut. "And once you reach that point as we did yesterday with the passing of the stimulus bill, the market is looking for the next catalyst to drive it forward."

Apple was an outlier amid a broad sell-off, gaining 3.6% and providing the biggest lift to all three major U.S. stock indexes on news of the company's plans to roll out an electric passenger vehicle by 2024. read more

Overnight, Congress passed a pandemic relief package worth $892 billion after months of a partisan tug-of-war, aimed at propping up an economic recovery faltering under the weight of restrictions aimed at containing a coronavirus resurgence. read more

That resurgence continues to swell, infecting 214,000 Americans every day, prompting mandatory shutdowns and pushing hospitals to capacity. read more

A fast-spreading new variant of the virus discovered in Britain has brought movement in and out of the UK to a halt and sent vaccine makers Pfizer Inc (PFE.N) and Moderna Inc (MRNA.O) scrambling to ensure their drugs were effective against it. read more

Fears of the coronavirus and optimism about an eventual economic recovery made for extreme volatility on Wall Street in 2020, with the S&P 500 logging daily gains or losses of 2% or more over 40 times in the year so far, the most in over a decade.

"The changes that have occurred in the world, I don't think anyone who's working today has seen anything like this," Pavlik added. "Nobody was prepared to deal with this situation where nearly the whole world was shut down."

On the economic front, consumer confidence unexpectedly dropped while sales of pre-owned U.S. homes posted their first decline in six months.

The Dow Jones Industrial Average (.DJI) fell 105.17 points, or 0.35%, to 30,111.28, the S&P 500 (.SPX) gained 1.18 points, or 0.03%, to 3,696.1 and the Nasdaq Composite (.IXIC) added 57.69 points, or 0.45%, to 12,800.21.

Of the 11 major sectors in the S&P 500, only tech (.SPLRCT) and real estate (.SPLRCR) were green.

Tesla Inc (TSLA.O) fell 2.4%, extending its slide on its second day as a S&P 500 constituent. read more

Peloton Interactive Inc (PTON.O) jumped 10.7% as brokers hiked their price targets on the stock on the heels of the company's announcement that it would buy peer Precor in a deal worth $420 million.

Amgen Inc (AMGN.O) slid 2.5% and was among the heaviest drags on the Dow, after disappointing results from a late-stage study of an asthma drug developed in a partnership with British drugmaker AstraZeneca Plc (AZN.L). read more

Declining issues outnumbered advancing ones on the NYSE by a 1.19-to-1 ratio; on Nasdaq, a 1.17-to-1 ratio favored advancers.

The S&P 500 posted 21 new 52-week highs and one new low; the Nasdaq Composite recorded 294 new highs and eight new lows.

Reporting by Stephen Culp; Additional reporting by Noel Randewich; Editing by Cynthia Osterman

Our Standards: The Thomson Reuters Trust Principles.